Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - Horizon Therapeutics Public Ltd Co | d910447d8k.htm |
| EX-99.3 - EXHIBIT 99.3 - Horizon Therapeutics Public Ltd Co | d910447dex993.htm |
| EX-99.2 - EXHIBIT 99.2 - Horizon Therapeutics Public Ltd Co | d910447dex992.htm |
| EX-99.1 - EXHIBIT 99.1 - Horizon Therapeutics Public Ltd Co | d910447dex991.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-198852) and Form S-8 (No. 333-198865) of Horizon Pharma plc of our report dated March 4, 2015 relating to the consolidated financial statements of Hyperion Therapeutics, Inc., which appears in this Current Report on Form 8-K of Horizon Pharma plc dated April 13, 2015.
/s/ PricewaterhouseCoopers LLP
San Jose, California
April 13, 2015